- Home
- SNCR vs OTLK Comparison
SNCR vs OTLK Comparison
Compare SNCR & OTLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNCR
- OTLK
- Stock Information
- Founded
- SNCR 2000
- OTLK 2010
- Country
- SNCR United States
- OTLK United States
- Employees
- SNCR N/A
- OTLK N/A
- Industry
- SNCR EDP Services
- OTLK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SNCR Technology
- OTLK Health Care
- Exchange
- SNCR Nasdaq
- OTLK Nasdaq
- Market Cap
- SNCR 137.5M
- OTLK 121.8M
- IPO Year
- SNCR 2006
- OTLK 2016
- Fundamental
- Price
- SNCR $8.95
- OTLK $5.41
- Analyst Decision
- SNCR
- OTLK Strong Buy
- Analyst Count
- SNCR 0
- OTLK 7
- Target Price
- SNCR N/A
- OTLK $48.20
- AVG Volume (30 Days)
- SNCR 100.4K
- OTLK 280.9K
- Earning Date
- SNCR 11-12-2024
- OTLK 12-20-2024
- Dividend Yield
- SNCR N/A
- OTLK N/A
- EPS Growth
- SNCR N/A
- OTLK N/A
- EPS
- SNCR N/A
- OTLK N/A
- Revenue
- SNCR $170,789,000.00
- OTLK N/A
- Revenue This Year
- SNCR $7.76
- OTLK N/A
- Revenue Next Year
- SNCR $5.83
- OTLK N/A
- P/E Ratio
- SNCR N/A
- OTLK N/A
- Revenue Growth
- SNCR 40.67
- OTLK N/A
- 52 Week Low
- SNCR $3.55
- OTLK $4.61
- 52 Week High
- SNCR $15.46
- OTLK $12.85
- Technical
- Relative Strength Index (RSI)
- SNCR 31.26
- OTLK 40.47
- Support Level
- SNCR $7.68
- OTLK $6.17
- Resistance Level
- SNCR $12.18
- OTLK $6.61
- Average True Range (ATR)
- SNCR 0.80
- OTLK 0.36
- MACD
- SNCR -0.14
- OTLK -0.05
- Stochastic Oscillator
- SNCR 28.22
- OTLK 10.80
About SNCR Synchronoss Technologies Inc.
Synchronoss Technologies Inc is a leading provider of white-label cloud, messaging, digital and network management solutions that enable its customers to keep subscribers, systems, networks and content in sync. The Synchronoss Personal CloudTM solution is designed to create an engaging and trusted customer experience through ongoing content management and engagement. The Synchronoss Personal CloudTM platform is a secure and highly scalable, white-label platform that allows its customers' subscribers to backup and protect, engage with, and manage their personal content. The company derives revenue from subscriptions and transaction-based fees. A majority of the firm's revenue is generated in the United States, and the rest is from countries across the world.
About OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.